Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 381 - 400 of 495 trials
Title Investigatorsort icon Disease(s)
A Phase I/II Study of Crizotinib and Ganetespib (STA-9090) in ALK-Positive Lung Cancers
[Protocol 12-015]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of the ALK Inhibitor CH5424802 in Patients with ALK-Rearranged Non-Small Cell Lung Cancer
[Protocol 12-113]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
Calypso-Based Deep Inspiration Breath Hold Radiation Treatment for Lung Cancer
[Protocol 13-174]
Rimner, Andreas
  • Lung Cancer
A Study Assessing the Predictive Value of Tumor Hypoxia (Low Oxygen Supply) in Patients with Non-Small Cell Lung Cancer
[Protocol 13-186]
Rimner, Andreas
  • Lung Cancer, Non-Small Cell
A Phase I Study of Stereotactic Body Radiation Therapy for Inoperable Locally Advanced Non-Small Cell Lung Cancer
Newly Diagnosed
[Protocol 13-113]
Rimner, Andreas
  • Lung Cancer, Non-Small Cell
A Study to See if Mesothelin Can Serve as a Marker of Early Lung Cancer
Newly Diagnosed
[Protocol 13-262]
Rizk, Nabil
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Cancer
[Protocol 11-037]
Rizk, Nabil
  • Esophageal Disorders
    • Barrett's Esophagus
  • Upper Gastrointestinal
    • Esophageal Cancer
A Prospective Study to Determine if Variations in Tissue Oxygenation Are Associated with Leak Rates after Esophagectomy
[Protocol 11-192]
Rizk, Nabil
  • Upper Gastrointestinal
    • Esophageal Cancer
Quality of Life Outcomes Following Minimally Invasive versus Open Esophagectomy for Esophageal Cancer
[Protocol 12-003]
Rizk, Nabil
  • Quality of Life
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase III Study of BMS-936558 versus Docetaxel in Previously Treated Advanced Squamous Cell Lung Cancer
[Protocol 12-203]
Rizvi, Naiyer
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Solid Tumors
A Phase IB Study of MPDL3280A plus Cobimetinib in Patients with Locally Advanced or Metastatic Solid Tumors
[Protocol 13-223]
Rizvi, Naiyer
  • Solid Tumors
A Phase I Study of Nivolumab with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189]
Rizvi, Naiyer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase Ib Study of Tremelimumab and MEDI4736 in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 13-197]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
Relapsed/Refractory
[Protocol 12-116]
Roberts, Stephen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase II Study of Veliparib plus Temozolomide, Veliparib plus Carboplatin and Paclitaxel, or Carboplatin and Paclitaxel with Placebo in Patients with BRCA Mutations and Metastatic Breast Cancer
[Protocol 12-122]
Robson, Mark
  • Breast Cancer
Understanding Decision-Making Processes for Undergoing Genetic Testing Among Women with Newly Diagnosed Breast Cancer
[Protocol 11-086]
Robson, Mark
  • Breast Cancer
  • Hereditary Cancer & Genetics